MaxCyte, Inc.
MXCT
$1.52
-$0.05-3.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.35% | -18.43% | -8.39% | -44.51% | 2.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.35% | -18.43% | -8.39% | -44.51% | 2.00% |
| Cost of Revenue | -17.22% | 2.08% | 6.70% | 45.01% | 143.13% |
| Gross Profit | -16.08% | -21.84% | -10.52% | -54.50% | -13.52% |
| SG&A Expenses | -28.58% | -2.74% | -1.69% | -10.50% | 0.62% |
| Depreciation & Amortization | 2.25% | 4.45% | -0.66% | -4.05% | -1.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.34% | 1.50% | -3.95% | -9.12% | 1.19% |
| Operating Income | 21.08% | -18.88% | -0.16% | -59.35% | -0.72% |
| Income Before Tax | -7.43% | -31.81% | -7.72% | -100.78% | -2.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.43% | -31.81% | -7.72% | -100.78% | -2.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.43% | -31.81% | -7.72% | -100.78% | -2.72% |
| EBIT | 21.08% | -18.88% | -0.16% | -59.35% | -0.72% |
| EBITDA | 22.80% | -20.69% | -0.31% | -69.35% | -0.90% |
| EPS Basic | -5.91% | -29.58% | -5.79% | -97.25% | -1.10% |
| Normalized Basic EPS | 20.09% | -29.64% | -5.77% | -97.48% | -1.03% |
| EPS Diluted | -5.91% | -29.58% | -5.79% | -97.25% | -1.10% |
| Normalized Diluted EPS | 20.09% | -29.64% | -5.77% | -97.48% | -1.03% |
| Average Basic Shares Outstanding | 1.43% | 1.69% | 1.79% | 1.78% | 1.60% |
| Average Diluted Shares Outstanding | 1.43% | 1.69% | 1.79% | 1.78% | 1.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |